Renal Cancer - Results from #2520

A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma. September 18, 2020

Validation of a Web-Based Planning Tool for Percutaneous Cryoablation of Renal Tumors. September 18, 2020

The role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes. September 18, 2020

Contemporary trends in percutaneous renal mass biopsy utilization in the United States. September 17, 2020

Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort. September 17, 2020

Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy. September 17, 2020

Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer. September 16, 2020

Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients. September 16, 2020

Patient factors predict complications after partial nephrectomy: Validation and calibration of the PREP (Preoperative Risk Evaluation for Partial Nephrectomy) score. September 16, 2020

Clear cell renal cell carcinoma with osseous metaplasia: Two extremely rare cases and review of the literature. September 15, 2020

Pathological features and outcomes of incidental renal cell carcinoma in candidate solid organ donors. September 15, 2020

Gender difference analysis of Xp11.2 translocation renal cell carcinomas's attack rate: a meta-analysis and systematic review. September 15, 2020

Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-Line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma. September 14, 2020

Perioperative and Long-Term Outcomes of Robot-Assisted Partial Nephrectomy: A Systematic Review. September 14, 2020

Pushing the limits of metastasis-directed treatment in metastatic renal cell carcinoma in the era of targeted therapy. September 14, 2020

Comparative Analysis of Antibiotic Exposure Association with Clinical Outcomes of Chemotherapy Versus Immunotherapy Across Three Tumour Types September 14, 2020

Outcomes in Patients with Renal Cell Carcinoma Undergoing Inferior Vena Cava Ligation without Reconstruction versus Thrombectomy: A Retrospective, Case-Controlled Study. September 11, 2020

Radiation induces dynamic changes to the T cell repertoire in renal cell carcinoma patients. September 11, 2020

Actin-binding protein Profilin1 promotes aggressiveness of clear cell renal cell carcinoma cells. September 11, 2020

Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer. September 11, 2020

Page 127 of 457